Interleukin-6 Inhibitors Improve Overall Survival Outcomes in Severe COVID-19
Investigators compared treatment with interleukin-6 inhibitors with standard of care among patients hospitalized with COVID-19 infection.
Hospital Medicine
Colchicine Shows Promise in Moderate and Severe COVID-19
Researchers evaluated the effect of adjuvant colchicine with standard therapy among patients with moderate and severe COVID-19 infection.
Increased Pancreatic Enzymes Prevalent in COVID-19 and Tied to Poor Outcomes
In this meta-analysis, researchers assessed whether an increase in pancreatic enzymes is associated with an increased risk for severe disease and poor outcomes in patients with COVID-19 infection.
Early Return-To-Work Program Mitigates Hospital Staffing Shortages During COVID-19
Graham M. Snyder, MD, MS, provides further insight into a study that evaluated the effects of an early return-to-work program that reduced the quarantine period for clinicians who remained asymptomatic after exposure to COVID-19.
Combine and Conquer: A Treatment Strategy to Combat Drug-Use Associated Infections
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
Association Between Delayed Antibiotic Administration and Risk for Septic Shock
Investigators conducted a study to determine whether early antibiotic administration decreases the risk for progression to septic shock among patients with suspected sepsis.
Can Strike Teams Relieve Hospital Staffing Shortages During COVID-19 Pandemic?
Expert calls Pennsylvania’s hospital strike teams short-sighted and a distraction from urgently needed evidence-based policy actions to improve nurse staffing issues.
Effect of Chlorhexidine Gluconate Bathing on Vancomycin-Resistant Enterococci Transmission
Investigators assessed whether daily bathing with 2% chlorhexidine gluconate decreases the risk for vancomycin-resistant enterococci (VRE) transmission in an intensive care unit with increased VRE endemicity.
Clinical Efficacy, Safety of Janus Kinase Inhibitors in Patients Hospitalized With COVID-19
Investigators conducted a meta-analysis of 3 randomized controlled trials that compared the clinical safety and efficacy of janus kinase inhibitors with placebo or standard care for the treatment of patients with COVID-19.
No Benefit From Continuous Positive Airway Pressure After Elective Major Intraperitoneal Surgery
Members of the PRISM trial group investigated whether CPAP administered immediately after major abdominal surgery could prevent postoperative morbidity.
- Loading...
Loading...
Next post in News
Loading... 
Loading...